XML 30 R56.htm IDEA: XBRL DOCUMENT v3.19.3
Related Party Transactions - Additional Information (Detail) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Related Party Transaction [Line Items]          
Accounts receivable from related party $ 17,662,000   $ 17,662,000   $ 47,210,000
Accrued liabilities to related party 954,000   954,000   444,000
Unbilled contract asset 180,000,000   180,000,000   0
Due from Related Parties, Current 126,012,000   126,012,000   0
Net unbilled contract asset 126,012,000   126,012,000   0
Deferred Revenue 53,988,000   53,988,000   0
Europe [Member]          
Related Party Transaction [Line Items]          
Unbilled contract asset 130,000,000.0   130,000,000.0    
Astellas Agreement [Member] | Europe [Member]          
Related Party Transaction [Line Items]          
Unbilled contract asset 130,000,000.0   130,000,000.0    
Deferred Revenue 3,988,000   3,988,000    
Astellas [Member] | Europe [Member]          
Related Party Transaction [Line Items]          
Unbilled contract asset 130,000,000.0   130,000,000.0    
Net unbilled contract asset 126,000,000.0   126,000,000.0    
Deferred Revenue 4,000,000.0   4,000,000.0    
Astellas [Member] | Collaborative Arrangement [Member]          
Related Party Transaction [Line Items]          
Revenue related to collaboration agreements 15,500,000 $ 5,100,000 155,000,000.0 $ 30,800,000  
Expense related to collaboration agreements 900,000 $ 400,000 2,200,000 $ 1,100,000  
Accounts receivable from related party 17,700,000   17,700,000   47,200,000
Accrued liabilities to related party 1,700,000   1,700,000   400,000
Astellas [Member] | Astellas Agreement [Member] | Milestone Payment [Member]          
Related Party Transaction [Line Items]          
Accrued liabilities to related party $ 12,500,000   $ 12,500,000    
Astellas [Member] | Astellas Agreement [Member] | Active Pharmaceutical Ingredients Shipment [Member]          
Related Party Transaction [Line Items]          
Accrued liabilities to related party         $ 43,800,000